Deep learning has become an essential element in various applications of technology over the past decades. Deep neural networks are now reaching performance on par with, or even beyond, human-level on a broad range of tasks. However, there are still several concerns and deficiencies that make these models impractical for some real-world applications. One of the important issues comes from a data-efficiency perspective. Most of the deep learning techniques need a large number of training samples in order to achieve a high performance on a given problem. This procedure is far from human general intelligence. Humans are good at learning from a few number of samples and quickly adapting to new tasks. In this work, we leverage the meta-learni...
© 2020 Richard LupatRapid advancement in genomic technologies has driven down the cost of sequencing...
BACKGROUND: Aggregating gene expression data across experiments via meta-analysis is expected to inc...
Predicting metastasis in the early stages means that clinicians have more time to adjust a treatment...
RNA sequencing has emerged as a promising approach in cancer prognosis as sequencing data becomes mo...
Background: Aggregating gene expression data across experiments via meta-analysis is expected to inc...
We show that by representing Single Nucleotide Polymorphism (SNP) data to a neural network in a way ...
International audienceBackground: Machine learning is now a standard tool for cancer prediction base...
Dissertação de mestrado em BioinformáticaCancer is one of the major causes of death in developed cou...
Cancer has become one of the major factors responsible for global deaths, due to late diagnoses and ...
Genomics profiling based on high dimensional data from high throughput experiments that measure the ...
Recent advances in the production of statistics have resulted in an exponential increase in the numb...
Modern machine learning methods have been widely applied in genomics and metagenomics data analysis....
One of the major challenges in cancer diagnosis from microarray data is to develop robust classifica...
The completion of the Human Genome Project in 2003 opened a new era for scientists. Through advanced...
In cancer, the primary tumour's organ of origin and histopathology are the strongest determinants of...
© 2020 Richard LupatRapid advancement in genomic technologies has driven down the cost of sequencing...
BACKGROUND: Aggregating gene expression data across experiments via meta-analysis is expected to inc...
Predicting metastasis in the early stages means that clinicians have more time to adjust a treatment...
RNA sequencing has emerged as a promising approach in cancer prognosis as sequencing data becomes mo...
Background: Aggregating gene expression data across experiments via meta-analysis is expected to inc...
We show that by representing Single Nucleotide Polymorphism (SNP) data to a neural network in a way ...
International audienceBackground: Machine learning is now a standard tool for cancer prediction base...
Dissertação de mestrado em BioinformáticaCancer is one of the major causes of death in developed cou...
Cancer has become one of the major factors responsible for global deaths, due to late diagnoses and ...
Genomics profiling based on high dimensional data from high throughput experiments that measure the ...
Recent advances in the production of statistics have resulted in an exponential increase in the numb...
Modern machine learning methods have been widely applied in genomics and metagenomics data analysis....
One of the major challenges in cancer diagnosis from microarray data is to develop robust classifica...
The completion of the Human Genome Project in 2003 opened a new era for scientists. Through advanced...
In cancer, the primary tumour's organ of origin and histopathology are the strongest determinants of...
© 2020 Richard LupatRapid advancement in genomic technologies has driven down the cost of sequencing...
BACKGROUND: Aggregating gene expression data across experiments via meta-analysis is expected to inc...
Predicting metastasis in the early stages means that clinicians have more time to adjust a treatment...